EUVIMEDEUVIMED entdecken
Crossref

Ergothioneine inhibits the progression of osteoarthritis via the Sirt6/NF-κB axis both in vitro and in vivo

Ze Wang, Jiawei Ma, Zhimin Miao, Yun Sun, Mingwei Dong, Yan Lin, Yaosen Wu, Zeming Sun

International Immunopharmacology · 2023-06 · 119 · 110211

DOI: 10.1016/j.intimp.2023.110211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-06. Verfasst von Ze Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, …. Hauptthemen laut MEDLINE: Ergothioneine, Osteoarthritis, Sirtuins. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA), which is a major cause of serious arthralgia and disability among the elderly, has long plagued numerous populations. However, the specific molecular mechanisms involved in the etiology of OA are unclear. SIRT6 plays a critical function in the development of several inflammatory and aging-associated diseases. A study by D'Onofrio demonstrates that ergothioneine (EGT) is an effective activator of SIRT6. As revealed by previous reports, EGT exerts beneficial effects on the mouse body, including resistance to oxidation, tumor, and inflammation. Therefore, this work attempted to identify the inflammatory resistance of EGT and explore its effects on the incidence and development of OA. Mouse chondrocyte stimulation using varying levels of EGT and 10 ng/mL IL-1β. According to in vitro experiments, EGT significantly reduced the decomposition of collagen II and aggrecan in OA chondrocytes, as well as inhibited the overexpression of PGE2, NO, IL-6, TNF-α, iNOs, COX-2, MMP-13, and ADAMTS5. In the present work, EGT hindered the NF-κB activity by activating the SIRT6 pathway in OA chondrocytes, which in turn, significantly attenuated the inflammatory response resulting from IL to 1β. The inhibitory effect of EGT on the progression of OA was demonstrated by the mouse DMM model experiment. Thus, this study revealed that EGT was effective in anti-OA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErgothioneineOsteoarthritisSirtuinsAnimalsMiceCells, CulturedChondrocytesDisease Models, AnimalInflammationInterleukin-1betaNF-kappa B

Stichwörter der Autor:innen

Anti-inflammatoryECMErgothioneineOsteoarthritisSirt6/NF-κB

Substanzen

ErgothioneineInterleukin-1betaNF-kappa BSirt6 protein, mouseSirtuins

Autor:innen und Institutionen

  • Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Z…
  • Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenz…

Zitieren

APA

Wang, Z., Ma, J., Miao, Z., Sun, Y., Dong, M., Lin, Y., Wu, Y., & Sun, Z. (2023). Ergothioneine inhibits the progression of osteoarthritis via the Sirt6/NF-κB axis both in vitro and in vivo. International Immunopharmacology, 119, 110211. https://doi.org/10.1016/j.intimp.2023.110211

Vancouver

Wang Z, Ma J, Miao Z, Sun Y, Dong M, Lin Y, et al. Ergothioneine inhibits the progression of osteoarthritis via the Sirt6/NF-κB axis both in vitro and in vivo. International Immunopharmacology. 2023;119:110211. doi:10.1016/j.intimp.2023.110211

BibTeX
@article{Wang2023,
  author = {Wang, Ze and Ma, Jiawei and Miao, Zhimin and Sun, Yun and Dong, Mingwei and Lin, Yan and Wu, Yaosen and Sun, Zeming},
  title = {Ergothioneine inhibits the progression of osteoarthritis via the Sirt6/NF-κB axis both in vitro and in vivo},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {119},
  pages = {110211},
  doi = {10.1016/j.intimp.2023.110211}
}
Kostenlos starten →